Speaker illustration

Ms Cindy Graebner

University Hospital Erlangen, Erlangen (Germany)

Pirfenidone treatment reduces cardiac allograft vasculopathy in a mouse model

Event: Frontiers in CardioVascular Biomedicine 2024

Topic: Heart Failure

Session: Poster session 1

Thumbnail

ESC 365 is supported by